Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Herrera AF, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Ansell SM, Moskowitz CH, Fenton K, Ogden CA, Taft D, Zhang Q, Kato K, Campbell M, Advani RH.

Blood. 2018 Mar 15;131(11):1183-1194. doi: 10.1182/blood-2017-10-811224. Epub 2017 Dec 11.

2.

Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging.

Santulli-Marotto S, Gervais A, Fisher J, Strake B, Ogden CA, Riveley C, Giles-Komar J.

PLoS One. 2015 Dec 16;10(12):e0145078. doi: 10.1371/journal.pone.0145078. eCollection 2015.

3.

Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma.

Ford CA, Petrova S, Pound JD, Voss JJ, Melville L, Paterson M, Farnworth SL, Gallimore AM, Cuff S, Wheadon H, Dobbin E, Ogden CA, Dumitriu IE, Dunbar DR, Murray PG, Ruckerl D, Allen JE, Hume DA, van Rooijen N, Goodlad JR, Freeman TC, Gregory CD.

Curr Biol. 2015 Mar 2;25(5):577-88. doi: 10.1016/j.cub.2014.12.059. Epub 2015 Feb 19.

4.

Validation of an instrument to measure quality of life in British children with inflammatory bowel disease.

Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG.

J Pediatr Gastroenterol Nutr. 2011 Sep;53(3):280-6. doi: 10.1097/MPG.0b013e3182165d10.

PMID:
21865975
5.

Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes.

Knowles H, Heizer JW, Li Y, Chapman K, Ogden CA, Andreasen K, Shapland E, Kucera G, Mogan J, Humann J, Lenz LL, Morrison AD, Perraud AL.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11578-83. doi: 10.1073/pnas.1010678108. Epub 2011 Jun 27.

6.

CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.

Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, Melville L, Melrose LA, Ogden CA, Nibbs R, Graham G, Combadiere C, Gregory CD.

Blood. 2008 Dec 15;112(13):5026-36. doi: 10.1182/blood-2008-06-162404. Epub 2008 Sep 17.

7.

Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism.

Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, Glatt SJ, Faraone SV, Nurnberger JI, Kuczenski R, Tsuang MT, Niculescu AB.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):134-66. doi: 10.1002/ajmg.b.30707.

PMID:
18247375
8.

Pilot evaluation of an instrument to measure quality of life in British children with inflammatory bowel disease.

Ogden CA, Abbott J, Aggett P, Derkx BH, Maity S, Thomas AG.

J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):117-20.

PMID:
18162847
9.

Innate and adaptive immune response to apoptotic cells.

Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB.

J Autoimmun. 2007 Dec;29(4):303-9. Epub 2007 Sep 20. Review.

10.

Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers.

Le-Niculescu H, McFarland MJ, Mamidipalli S, Ogden CA, Kuczenski R, Kurian SM, Salomon DR, Tsuang MT, Nurnberger JI Jr, Niculescu AB.

Neurosci Biobehav Rev. 2007;31(6):897-903. Epub 2007 Jun 3. Review.

11.

PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes.

Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ, Caligiuri MP, Lohr JB.

Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):653-62.

PMID:
16838358
12.

Recognition ligands on apoptotic cells: a perspective.

Gardai SJ, Bratton DL, Ogden CA, Henson PM.

J Leukoc Biol. 2006 May;79(5):896-903. Review.

PMID:
16641135
13.

Role of complement and other innate immune mechanisms in the removal of apoptotic cells.

Ogden CA, Elkon KB.

Curr Dir Autoimmun. 2006;9:120-42. Review.

PMID:
16394658
14.

Convergent functional genomics: a Bayesian candidate gene identification approach for complex disorders.

Bertsch B, Ogden CA, Sidhu K, Le-Niculescu H, Kuczenski R, Niculescu AB.

Methods. 2005 Nov;37(3):274-9.

PMID:
16308156
15.

IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo.

Ogden CA, Kowalewski R, Peng Y, Montenegro V, Elkon KB.

Autoimmunity. 2005 Jun;38(4):259-64.

PMID:
16206508
16.

Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.

Ogden CA, Pound JD, Batth BK, Owens S, Johannessen I, Wood K, Gregory CD.

J Immunol. 2005 Mar 1;174(5):3015-23.

17.

Single-dose therapy for lupus nephritis: C-reactive protein, nature's own dual scavenger and immunosuppressant.

Ogden CA, Elkon KB.

Arthritis Rheum. 2005 Feb;52(2):378-81. No abstract available.

18.

Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice.

Devitt A, Parker KG, Ogden CA, Oldreive C, Clay MF, Melville LA, Bellamy CO, Lacy-Hulbert A, Gangloff SC, Goyert SM, Gregory CD.

J Cell Biol. 2004 Dec 20;167(6):1161-70.

19.

Macrophage chemotaxis to apoptotic Burkitt's lymphoma cells in vitro: role of CD14 and CD36.

Truman LA, Ogden CA, Howie SE, Gregory CD.

Immunobiology. 2004;209(1-2):21-30.

PMID:
15481137
20.

Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.

Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB.

Mol Psychiatry. 2004 Nov;9(11):1007-29.

PMID:
15314610

Supplemental Content

Loading ...
Support Center